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reports of incremental results, sensitivity analysis, and mention
of caveats. Outright budget impact models were not evaluated.
RESULTS: Of 35 dossiers submitted during 2003, 27 (77%)
included economic models. Of these, model type was justiﬁed in
8 (29%); time horizon stated in 22 (82%); discount rate stated
in 5 (19%); relevance of productivity changes discussed in 1
(4%) but reported in none; resource quantities reported sepa-
rately in 3 (11%); relevant alternatives compared in 11 (41%);
incremental results reported in 5 (19%); some form of sensitiv-
ity analysis in 15 (56%); caveats to conclusions mentioned in 4
(15%).Models of me-too drugs were signiﬁcantly less likely to
report comparisons against relevant alternatives (OR = 0.08, p
= 0.011) or incremental results (OR = 0.07, p = 0.03). No other
signiﬁcant differences were found. CONCLUSIONS: Most
dossiers submitted to one health plan in 2003 under the AMCP
Format contained economic models. Models had low levels of
compliance with broadly accepted recommendations. Models of
me-too drugs may be particularly prone to bias.
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OBJECTIVE: To test the hypothesis that the corporate structure
of large health insurance companies affects formulary design. By
choosing what is solely at the discretion of pharmacy beneﬁt
managers (PBMs), their national formularies, as the dependent
variable, rather than the generic utilization rate, the need to
factor out extraneous demand factors was minimized.
METHODS: The 2004 published formularies of the following
three groups were examined: a) the national formularies of four
large independent PBMs; b) the formularies of six large insur-
ance companies that have contracted with these large PBMs to
managed their drug beneﬁt plans; and c) the formularies of 
four large insurance companies that manage PBM functions
internally. Three therapeutic classes—proton pump inhibitors, 
COX-2 inhibitors, and second generation antihistamines—were
selected on the basis of widespread claims of the existence of
lower cost generics that are therapeutic equivalents. The number
of brand name drugs selected for the “Tier 2” was tallied for
each formulary across the three selected therapeutic classes.
RESULTS: There was no signiﬁcant difference in the number 
of “Tier 2” brand name drugs in the selected therapeutic 
classes of formularies of the large insurance companies with 
differing corporate structures. However, there was signiﬁcant
drop off in the number of brands included in the national for-
mularies of the four large, independent PBMs and the number
of brands in the “Tier 2” of ﬁnal plan formularies chosen 
by their clients. CONCLUSION: Large insurance companies
relying on independent PBMs for formulary management take
an active role in the design process and neutralize the effect that
corporate structure has on the starting point of the design
process.
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OBJECTIVE: To determine and evaluate the rate at which
abstracts presented at the ISPOR International and European
Congress Meetings during 2000–2003 were published.
METHODS: All contributed research abstracts categorized in
the Mental Health area during the 2000–2003 ISPOR Interna-
tional and European annual conferences that were posted on the
ISPOR website were searched for possible publications stemming
from the abstract. Both PubMed and Medline search engines
were used. For each abstract, the on-line search was initiated
using the ﬁrst author’s name, and then keywords within the title.
If no match was found, the next author was searched in a similar
fashion, until all the authors listed on the abstract were evalu-
ated. Publications that were similar in title, methods, results and
conclusions were considered a match. RESULTS: A total of 287
mental health abstracts were included in the study. Fifty-four
publications were identiﬁed in a total of 34 different journals.
The Journal of Clinical Psychiatry (6/54 = 11.1%) had the most
publications. The publication rates for the ISPOR International
conference in the years 2000, 2001, 2002, and 2003 were
22.6%, 22.5%, 20.8%, and 14.5%, respectively. The overall
publication rate of ISPOR International mental health abstracts
was 19.3%. In comparison, the ISPOR European publication
rates of mental health abstracts presented from 2000 to 2003
were 42.1%, 37.9%, 10.7% and 10%, respectively. With an
overall publication rate of 23.6%, slightly higher than the ISPOR
international publication rate. CONCLUSION: Pooled data
from the European and International ISPOR meetings showed a
publication rate between 13.0 and 30.0%. The publication rate
was highest in 2000 with a rate of 30.0% followed by publica-
tion rate of 29% in 2001, 17.1% in 2002 and 13.0% in 2003.
This trend of greater publication rates in the earlier years is not
unexpected given the lag time between submission, acceptance
and publication.
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OBJECTIVES: Emergency department (ED) use and costs were
examined for care of non-emergency problems during a one year
period for a patient cohort noted to be “homeless”. METHODS:
Using 2001–2002 Massachusetts ED data, a patient cohort was
identiﬁed by personal identiﬁers and the “homeless” indicator.
Visit reason was determined using ICD-9 diagnosis and visit
status codes. A non-emergency visit was deﬁned by a status other
than “emergency” and/or diagnosis not indicating a life threat-
ening condition (e.g., myocardial infraction) or injury. An ED
visit proﬁle was established for each patient over a one-year
period by tracking all non-emergency ED visits for 12 months
for each patient. Cost estimates, reported in 2004 USD, include
accommodations and ancillaries. Charges were adjusted using 
a 0.55 cost-to-charge ratio and appropriate inﬂation indices.
RESULTS: Less than 1% of ED visits were noted to be for 
homeless persons; however, 58% of ED cases had “unknown”
recorded for homeless status. Of the 2452 ED patients recorded
as homeless, 1244 (51%) were treated for non-emergency prob-
lems (males = 69%, mean age = 43 years). On average, these
patients had 1.4 non-emergency ED visits during the year (range:
1–14). Reason for visit: chronic and other medical = 28%,
alcohol/drug related = 27%, psychiatric = 14%, routine
exam/dental/ENT/eye = 10%, musculoskeletal = 10%, infection
= 9%, OB/GYN = 2%. Mean ED visit was 4.8 hours (median:
